Exact Sciences Corporation
EXAS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,028,857 | -$204,149 | -$623,506 | -$595,625 |
| Dep. & Amort. | $214,859 | $206,608 | $197,558 | $180,346 |
| Deferred Tax | -$10,119 | -$955 | -$11,901 | -$253,169 |
| Stock-Based Comp. | $214,885 | $231,312 | $206,823 | $253,063 |
| Change in WC | -$56,012 | -$342 | -$26,377 | $111,109 |
| Other Non-Cash | $875,780 | -$76,355 | $33,844 | $202,040 |
| Operating Cash Flow | $210,536 | $156,119 | -$223,559 | -$102,236 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$135,989 | -$124,190 | -$214,462 | -$135,766 |
| Net Acquisitions | -$45,000 | -$52,413 | -$14,686 | -$517,774 |
| Inv. Purchases | -$466,762 | -$156,418 | -$174,309 | -$1,164,050 |
| Inv. Sales/Matur. | $205,821 | $382,950 | $453,072 | $794,322 |
| Other Inv. Act. | -$225 | -$250 | $24,451 | -$58,817 |
| Investing Cash Flow | -$442,155 | $49,679 | $74,066 | -$1,082,085 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $216,750 | $137,976 | $50,000 | -$23,749 |
| Stock Issued | $32,878 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$17,754 | $21,790 | $26,485 | $32,221 |
| Financing Cash Flow | $231,874 | $159,766 | $76,485 | $8,472 |
| Forex Effect | -$3,294 | $1,321 | $30 | $23 |
| Net Chg. in Cash | -$3,039 | $366,885 | -$72,978 | -$1,175,826 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $609,675 | $242,790 | $315,768 | $1,491,594 |
| End Cash | $606,636 | $609,675 | $242,790 | $315,768 |
| Free Cash Flow | $74,547 | $31,929 | -$438,021 | -$238,002 |